Naunheim, Matthew R. http://orcid.org/0000-0002-3927-3984
Huston, Molly N.
Article History
Accepted: 9 July 2023
First Online: 2 August 2023
Declarations
:
: Dr. Naunheim is a consultant for Kytarro Limited, Mosanna Therapeutics, and Best-in-Class MD for work unrelated to this paper. No other disclosures. There is no conflict of interest for any of the authors related to the current presentation.
: This article does not contain any studies with human or animal subjects performed by any of the authors.